Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H27N5O3.ClH |
Molecular Weight | 421.921 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN(CCO)CCN1C(CC2=CC=CC=C2)=NC3=C1C(=O)N(C)C(=O)N3C
InChI
InChIKey=PDBXHPORMXSXKO-UHFFFAOYSA-N
InChI=1S/C20H27N5O3.ClH/c1-4-24(12-13-26)10-11-25-16(14-15-8-6-5-7-9-15)21-18-17(25)19(27)23(3)20(28)22(18)2;/h5-9,26H,4,10-14H2,1-3H3;1H
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P30542 Gene ID: 134.0 Gene Symbol: ADORA1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/8781823 |
PubMed
Title | Date | PubMed |
---|---|---|
UC blood infection with clinical strains of Mycobacterium tuberculosis: a novel model. | 2007 |
|
In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function. | 2008 Jun 1 |
|
Single channel studies of the ATP-regulated potassium channel in brain mitochondria. | 2009 Aug |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7716349
600 mg b.d. for 15 days
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C319
Created by
admin on Fri Dec 15 15:04:06 GMT 2023 , Edited by admin on Fri Dec 15 15:04:06 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
243-967-6
Created by
admin on Fri Dec 15 15:04:06 GMT 2023 , Edited by admin on Fri Dec 15 15:04:06 GMT 2023
|
PRIMARY | |||
|
20684-06-4
Created by
admin on Fri Dec 15 15:04:06 GMT 2023 , Edited by admin on Fri Dec 15 15:04:06 GMT 2023
|
PRIMARY | |||
|
68549
Created by
admin on Fri Dec 15 15:04:06 GMT 2023 , Edited by admin on Fri Dec 15 15:04:06 GMT 2023
|
PRIMARY | |||
|
DTXSID4048721
Created by
admin on Fri Dec 15 15:04:06 GMT 2023 , Edited by admin on Fri Dec 15 15:04:06 GMT 2023
|
PRIMARY | |||
|
100000091601
Created by
admin on Fri Dec 15 15:04:06 GMT 2023 , Edited by admin on Fri Dec 15 15:04:06 GMT 2023
|
PRIMARY | |||
|
66466QLM3S
Created by
admin on Fri Dec 15 15:04:06 GMT 2023 , Edited by admin on Fri Dec 15 15:04:06 GMT 2023
|
PRIMARY | |||
|
DBSALT002675
Created by
admin on Fri Dec 15 15:04:06 GMT 2023 , Edited by admin on Fri Dec 15 15:04:06 GMT 2023
|
PRIMARY | |||
|
236152
Created by
admin on Fri Dec 15 15:04:06 GMT 2023 , Edited by admin on Fri Dec 15 15:04:06 GMT 2023
|
PRIMARY | RxNorm | ||
|
C76574
Created by
admin on Fri Dec 15 15:04:06 GMT 2023 , Edited by admin on Fri Dec 15 15:04:06 GMT 2023
|
PRIMARY | |||
|
m2218
Created by
admin on Fri Dec 15 15:04:06 GMT 2023 , Edited by admin on Fri Dec 15 15:04:06 GMT 2023
|
PRIMARY | Merck Index | ||
|
C006683
Created by
admin on Fri Dec 15 15:04:06 GMT 2023 , Edited by admin on Fri Dec 15 15:04:06 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110760
Created by
admin on Fri Dec 15 15:04:06 GMT 2023 , Edited by admin on Fri Dec 15 15:04:06 GMT 2023
|
PRIMARY | |||
|
SUB12981MIG
Created by
admin on Fri Dec 15 15:04:06 GMT 2023 , Edited by admin on Fri Dec 15 15:04:06 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD